Detailed company information
Ocugen, Inc. is a biopharmaceutical company in the clinical development phase, primarily dedicated to pioneering gene therapies aimed at treating various ophthalmic conditions leading to blindness. The company's developmental pipeline features several key candidates: OCU400: An innovative gene therapy designed to reinstate both the function and structural integrity of the retina across a broad spectrum of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and Leber congenital amaurosis. OCU410: Another gene therapy candidate, currently being developed to address dry age-related macular degeneration (AMD). OCU200: A novel fusion protein, presently undergoing preclinical evaluation for its potential in treating diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen maintains significant strategic collaborations, including a partnership with CanSino Biologics Inc. for the joint development and manufacturing of gene therapies, and an alliance with Bharat Biotech for the commercialization of COVAXIN within the United States market. The company's corporate headquarters are situated in Malvern, Pennsylvania.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q2Released: Aug 06, 2026
Earnings Transcript for 2025 - Q4Released: Mar 04, 2026
Earnings Transcript for 2025 - Q3Released: Nov 05, 2025
Earnings Transcript for 2025 - Q2Released: Aug 01, 2025
Earnings Transcript for 2025 - Q1Released: May 09, 2025
Earnings Transcript for 2024 - Q4Released: Mar 05, 2025
Earnings Transcript for 2024 - Q3Released: Nov 08, 2024
Earnings Transcript for 2024 - Q2Released: Aug 08, 2024
Earnings Transcript for 2024 - Q1Released: May 14, 2024
Earnings Transcript for 2023 - Q4Released: Apr 02, 2024
Earnings Transcript for 2023 - Q3Released: Nov 09, 2023
Earnings Transcript for 2023 - Q2Released: Aug 22, 2023
Earnings Transcript for 2023 - Q1Released: May 05, 2023
Earnings Transcript for 2022 - Q4Released: Feb 28, 2023
Earnings Transcript for 2022 - Q3Released: Nov 08, 2022
Earnings Transcript for 2022 - Q2Released: Aug 05, 2022
Earnings Transcript for 2022 - Q1Released: May 06, 2022
Earnings Transcript for 2021 - Q4Released: Feb 25, 2022
Earnings Transcript for 2021 - Q3Released: Nov 09, 2021
Earnings Transcript for 2021 - Q2Released: Aug 06, 2021
Earnings Transcript for 2021 - Q1Released: May 07, 2021
Earnings Transcript for 2020 - Q4Released: Mar 18, 2021
Earnings Transcript for 2020 - Q2Released: Aug 17, 2020
Earnings Transcript for 2019 - Q4Released: Mar 27, 2020
Dafinchi
